F8 and hemophilia A: Protein substitution therapy, performed on a regular basis, is the only effectivetreatment for hemophilia A. The traditional source of FVIII is donated blood plasma,which is in short supply and poses a significant risk of virus [1, 2] andprions [3] transmission, even after rigorousplasma batches screening and multiple viral inactivation procedures.